117 related articles for article (PubMed ID: 29127567)
1. The root of Actinidia chinensis inhibits hepatocellular carcinomas cells through LAMB3.
Hou J; Wang L; Wu D
Cell Biol Toxicol; 2018 Aug; 34(4):321-332. PubMed ID: 29127567
[TBL] [Abstract][Full Text] [Related]
2. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.
Fang T; Hou J; He M; Wang L; Zheng M; Wang X; Xia J
Cell Biol Toxicol; 2016 Dec; 32(6):499-511. PubMed ID: 27475644
[TBL] [Abstract][Full Text] [Related]
3. Actinidia chinensis Planch root extract inhibits cholesterol metabolism in hepatocellular carcinoma through upregulation of PCSK9.
He M; Hou J; Wang L; Zheng M; Fang T; Wang X; Xia J
Oncotarget; 2017 Jun; 8(26):42136-42148. PubMed ID: 28178673
[TBL] [Abstract][Full Text] [Related]
4. Actinidia Chinensis Planch Root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway.
Fang T; Zhao Z; Yuan F; He M; Sun J; Guo M; Huang P; Yang B; Xia J
J Ethnopharmacol; 2020 Apr; 251():112529. PubMed ID: 31891797
[TBL] [Abstract][Full Text] [Related]
5. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition.
Fang T; Fang Y; Xu X; He M; Zhao Z; Huang P; Yuan F; Guo M; Yang B; Xia J
J Ethnopharmacol; 2019 Mar; 231():474-485. PubMed ID: 30415058
[TBL] [Abstract][Full Text] [Related]
6. Regulatory roles of OASL in lung cancer cell sensitivity to Actinidia chinensis Planch root extract (acRoots).
Lv J; Wang L; Shen H; Wang X
Cell Biol Toxicol; 2018 Jun; 34(3):207-218. PubMed ID: 29508110
[TBL] [Abstract][Full Text] [Related]
7. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
8. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
[TBL] [Abstract][Full Text] [Related]
9. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
10. Total saponin from root of Actinidia valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells.
Zheng GY; Xin HL; Li B; Xu YF; Yi TJ; Ling CQ
Chin J Integr Med; 2012 Mar; 18(3):197-202. PubMed ID: 22466944
[TBL] [Abstract][Full Text] [Related]
11. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
Zhao H; Zhang Y; Sun J; Zhan C; Zhao L
Oncol Res; 2016; 23(5):237-48. PubMed ID: 27098147
[TBL] [Abstract][Full Text] [Related]
12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
Huang H; Hu M; Zhao R; Li P; Li M
Oncol Rep; 2013 Nov; 30(5):2467-75. PubMed ID: 24002546
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract][Full Text] [Related]
15. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
[TBL] [Abstract][Full Text] [Related]
17. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
18. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathway in vitro.
Qu L; Zhang H; Yang Y; Yang G; Xin H; Ling C
Pharm Biol; 2016 Aug; 54(8):1445-57. PubMed ID: 26810384
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
20. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
